论著 · 基础研究

GPI锚定丝氨酸蛋白酶testisin的活化机制研究

  • 万家惠 ,
  • 周爱武
展开
  • 上海交通大学基础医学院病理生理学系,上海 200025
万家惠(1996—),女,硕士生;电子信箱:tourmaline_w@163.com
周爱武,电子信箱:aiwu.zhou@googlemail.com

收稿日期: 2024-04-12

  录用日期: 2024-05-28

  网络出版日期: 2024-12-28

基金资助

国家自然科学基金(32371306)

Mechanistic studies on regulation of the activity of GPI-anchored serine protease testisin

  • Jiahui WAN ,
  • Aiwu ZHOU
Expand
  • Department of Pathophysiology, Shanghai Jiao Tong University College of Basic Medical Sciences, Shanghai 200025, China
ZHOU Aiwu, E-mail: aiwu.zhou@googlemail.com.

Received date: 2024-04-12

  Accepted date: 2024-05-28

  Online published: 2024-12-28

Supported by

National Natural Science Foundation of China(32371306)

摘要

目的·探讨睾丸素(testisin)酶原在体外的活化方式及活性调控机制,为进一步研究testisin在生物体内的生理功能奠定基础。方法·通过全基因合成,构建鼠源testisin(mTN)蛋白酶原的真核表达质粒,并将其转染至真核HEK293S细胞中;通过镍离子亲和层析等方法获得纯化重组testisin蛋白;将酶原激活位点和活性中心位点进行定点突变,利用酶活性检测等手段分析testisin的活化机制,通过改变酶原的孵育条件确定蛋白的活化速率;利用Edman降解法及定点突变确定蛋白酶的自剪切位点;通过检测蛋白对底物的分解速率分析蛋白酶的活性调控机制。结果·重组mTN酶原在真核HEK293S细胞中高效表达,通过一步纯化可以获得纯度较高且性质均一的重组蛋白。该蛋白在酸性条件下稳定,在中性或碱性环境下会发生自激活,其激活速率受到酸碱度和温度等因素的影响,且这种自激活依赖于该酶激活位点Arg46和酶活性中心Ser240的完整性。重组mTN酶原的活化常伴随分子表面170/175肽环的自剪切,但该自剪切并不影响其蛋白酶的活性。活化的mTN最适反应pH值为8.0,且在其最适pH值附近较为稳定;最适反应温度为50 ℃,且蛋白适宜保存在低于30 ℃的环境中;Zn2+和Ca2+对mTN的活性有明显的抑制作用。结论·成功建立了一种有效制备重组mTN酶原的方法,发现重组mTN在体外可以发生自激活和自剪切。

本文引用格式

万家惠 , 周爱武 . GPI锚定丝氨酸蛋白酶testisin的活化机制研究[J]. 上海交通大学学报(医学版), 2024 , 44(12) : 1504 -1513 . DOI: 10.3969/j.issn.1674-8115.2024.12.003

Abstract

Objective ·To explore the activation methods and activity regulation mechanisms of the testisin zymogen in vitro, laying a foundation for further research on the physiological functions of testisin in organisms. Methods ·The eukaryotic expression plasmid for the mouse-derived testisin (mTN) zymogen was constructed through full-gene synthesis and subsequently transfected into eukaryotic HEK293S cells for expression. Purified recombinant testisin protein was obtained through methods such as nickel ion affinity chromatography. Site-directed mutagenesis was performed on the activation site and active center of the zymogen, and the activation mechanism of testisin was analyzed through enzymatic activity assays. Additionally, the activation rate of the protein was determined by altering the incubation conditions of the zymogen. The self-cleavage site of the protease was identified by using Edman degradation and site-directed mutagenesis. Finally, the regulatory mechanism of protease activity was examined by analyzing the proteolytic rate of the protein towards its substrates. Results ·The recombinant mTN zymogen was expressed in eukaryotic HEK293S cells, and high-purity, uniform recombinant protein was obtained through a two-step purification process. This protein was found to remain stable under acidic conditions but underwent self-activation in neutral or alkaline environments. The rate of activation was influenced by factors such as pH value and temperature. The self-activation process required on the integrity of the enzyme's activation site, Arg46, and its active center, Ser240. Additionally, the self-activation of the recombinant mTN zymogen was often accompanied by the self-cleavage at the 170/175 loop on the molecular surface, but this self-cleavage did not affect the activity of testisin. Furthermore, the optimal reaction pH for activated mTN was 8.0, with the protein remaining relatively stable near this pH. The optimal reaction temperature was 50 ℃, while the protein was best stored at temperatures below 30 ℃. Zn2+ and Ca2+ were found to significantly inhibit mTN activity. Conclusion ·An effective method for the preparation of recombinant mTN zymogen is successfully established, and it is discovered that the recombinant mTN undergoes self-activation and self-cleavage in vitro.

参考文献

1 HEDSTROM L. Serine protease mechanism and specificity[J]. Chem Rev, 2002, 102(12): 4501-4524.
2 RAWLINGS N D, MORTON F R, KOK C Y, et al. MEROPS: the peptidase database[J]. Nucleic Acids Res, 2008, 36(Database issue): D320-D325.
3 ANTALIS T M, BUZZA M S, HODGE K M, et al. The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment[J]. Biochem J, 2010, 428(3): 325-346.
4 DI CERA E. Serine proteases [J]. IUBMB Life, 2009, 61(5): 510-515.
5 HEDSTROM L. Serine protease mechanism and specificity[J]. Chem Rev, 2002, 102(12): 4501-4524.
6 ANTALIS T M, BUGGE T H, WU Q Y. Membrane-anchored serine proteases in health and disease[J]. Prog Mol Biol Transl Sci, 2011, 99: 1-50.
7 VERGHESE G M, GUTKNECHT M F, CAUGHEY G H. Prostasin regulates epithelial monolayer function: cell-specific Gpld1-mediated secretion and functional role for GPI anchor[J]. Am J Physiol Cell Physiol, 2006, 291(6): C1258-C1270.
8 HONDA A, YAMAGATA K, SUGIURA S, et al. A mouse serine protease TESP5 is selectively included into lipid rafts of sperm membrane presumably as a glycosylphosphatidylinositol-anchored protein[J]. J Biol Chem, 2002, 277(19): 16976-16984.
9 HOOPER J D, NICOL D L, DICKINSON J L, et al. testisin, a new human serine proteinase expressed by premeiotic testicular germ cells and lost in testicular germ cell tumors[J]. Cancer Res, 1999, 59(13): 3199-3205.
10 TANG T, KMET M, CORRAL L, et al. testisin, a glycosyl-phosphatidylinositol-linked serine protease, promotes malignant transformation in vitro and in vivo[J]. Cancer Res, 2005, 65(3): 868-878.
11 YEOM S Y, JANG H L, LEE S J, et al. Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cells[J]. FEBS Lett, 2010, 584(8): 1469-1475.
12 AIMES R T, ZIJLSTRA A, HOOPER J D, et al. Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis[J]. Thromb Haemost, 2003, 89(3): 561-572.
13 DRIESBAUGH K H, BUZZA M S, MARTIN E W, et al. Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin[J]. J Biol Chem, 2015, 290(6): 3529-3541.
14 PEROUTKA R J, BUZZA M S, MUKHOPADHYAY S, et al. testisin/Prss21 deficiency causes increased vascular permeability and a hemorrhagic phenotype during luteal angiogenesis[J]. PLoS One, 2020, 15(6): e0234407.
15 L'ABBé D, BISSON L, GERVAIS C, et al. Transient gene expression in suspension HEK293-EBNA1 cells[J]. Methods Mol Biol, 2018, 1850: 1-16.
16 FUSEK M, LIN X L, TANG J. Enzymic properties of thermopsin[J]. J Biol Chem, 1990, 265(3): 1496-1501.
17 GOETTIG P, BRANDSTETTER H, MAGDOLEN V. Surface loops of trypsin-like serine proteases as determinants of function[J]. Biochimie, 2019, 166: 52-76.
18 CEDERHOLM-WILLIAMS S A. Concentration of plasminogen and antiplasmin in plasma and serum[J]. J Clin Pathol, 1981, 34(9): 979-981.
19 CESARMAN-MAUS G, HAJJAR K A. Molecular mechanisms of fibrinolysis[J]. Br J Haematol, 2005, 129(3): 307-321.
20 WU Q Y, PARRY G. Hepsin and prostate cancer[J]. Front Biosci, 2007, 12: 5052-5059.
21 DONG N Z, ZHOU T T, ZHANG Y, et al. Corin mutations K317E and S472G from preeclamptic patients alter zymogen activation and cell surface targeting.[Corrected][J]. J Biol Chem, 2014, 289(25): 17909-17916.
22 SHI Y E, TORRI J, YIEH L, et al. Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells[J]. Cancer Res, 1993, 53(6): 1409-1415.
23 JIN X L, HIROSAKI T, LIN C Y, et al. Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin[J]. J Cell Biochem, 2005, 95(3): 632-647.
24 BENAUD C, DICKSON R B, LIN C Y. Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor[J]. Eur J Biochem, 2001, 268(5): 1439-1447.
25 AFAR D E, VIVANCO I, HUBERT R S, et al. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia[J]. Cancer Res, 2001, 61(4): 1686-1692.
26 LUCAS J M, TRUE L, HAWLEY S, et al. The androgen-regulated type Ⅱ serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma[J]. J Pathol, 2008, 215(2): 118-125.
27 TANABE L M, LIST K. The role of type Ⅱ transmembrane serine protease-mediated signaling in cancer[J]. FEBS J, 2017, 284(10): 1421-1436.
28 PAWAR N R, BUZZA M S, ANTALIS T M. Membrane-anchored serine proteases and protease-activated receptor-2-mediated signaling: co-conspirators in cancer progression[J]. Cancer Res, 2019, 79(2): 301-310.
29 TRUEBESTEIN L, TENNSTAEDT A, M?NIG T, et al. Substrate-induced remodeling of the active site regulates human HTRA1 activity[J]. Nat Struct Mol Biol, 2011, 18(3): 386-388.
30 LECHTENBERG B C, MURRAY-RUST T A, JOHNSON D J, et al. Crystal structure of the prothrombinase complex from the venom of Pseudonaja textilis[J]. Blood, 2013, 122(16): 2777-2783.
31 REYDA S, SOHN C, KLEBE G, et al. Reconstructing the binding site of factor Ⅹa in trypsin reveals ligand-induced structural plasticity[J]. J Mol Biol, 2003, 325(5): 963-977.
文章导航

/